Sfoglia per Autore
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts
2012 Porru, M; Zappavigna, S; Luce, A; Panico, A; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
2012 Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
2012 Marra, M; Salzano, G; Leonetti, C; Porru, M; Franco, Renato; Zappavigna, S; Liguori, G; Botti, G; Chieffi, Paolo; Lamberti, Monica; Vitale, G; Abbruzzese, A; La Rotonda, Mi; De Rosa, G; Caraglia, Michele
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.
2012 Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
2012 Vitale, G; Zappavigna, S; Marra, M; Dicitore, A; Meschini, S; Condello, M; Arancia, G; Castiglioni, S; Maroni, P; Bendinelli, P; Piccoletti, R; van Koetsveld, Pm; Cavagnini, F; Budillon, A; Abbruzzese, A; Hofland, Lj; Caraglia, Michele
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells.
2012 Sanges, C; Scheuermann, C; Zahedi, Rp; Sickmann, A; Lamberti, A; Migliaccio, N; Baljuls, A; Marra, M; Zappavigna, S; Reinders, J; Rapp, U; Abbruzzese, A; Caraglia, Michele; Arcari, P.
Autophagic cell death: A new frontier in cancer research
2013 Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M.
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO
2013 Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation
2013 Perna, A; Sepe, I; Lanza, D; Capasso, R; Zappavigna, S; Capasso, G; Caraglia, M; Ingrosso, D.
Interleukin 18: Friend or foe in cancer.
2013 Palma, G; Barbieri, A; Bimonte, S; Palla, M; Zappavigna, S; Caraglia, Michele; Ascierto, Pa; Ciliberto, G; Arra, C.
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain.
2013 Caraglia, Michele; Luongo, Livio; Salzano, G; Zappavigna, S; Marra, M; Guida, Francesca; Lusa, S; Giordano, C; DE NOVELLIS, Vito; Rossi, Francesco; Abbruzzese Saccardi, A; De Rosa, G; Maione, Sabatino
Emerging pathways as individualized therapeutic target of multiple myeloma.
2013 Misso, Gabriella; Zappavigna, S; Castellano, M; De Rosa, G; Di Martino, Mt; Tagliaferri, P; Tassone, P; Caraglia, Michele
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?
2013 Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G.
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma
2013 Leonetti, ; C, ; Porru, ; M, ; Artuso, ; S, ; Zappavigna, S; Luce, ; A, ; Salzano, ; G, ; Lusa, ; S, ; De, Rosa; G, ; Caraglia, ; M,
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.
2013 Troiani, Teresa; Zappavigna, S; Martinelli, Erika; Addeo, Sr; Stiuso, Paola; Ciardiello, Fortunato; Caraglia, Michele
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
2013 Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
2014 Franco, Renato; Zappavigna, S; Gigantino, V; Luce, A; Cantile, M; Cerrone, M; Facchini, G; Perdonà, S; Pignata, S; Di Lorenzo, G; Chieffi, Sergio; Vitale, G; DE SIO, Marco; Sgambato, A; Botti, G; Yousif, Am; Novellino, E; Grieco, P; Caraglia, Michele
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
2014 Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.
2014 Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele
Erlotinib: early clinical development in brain cancer.
2014 Addeo, R; Zappavigna, S; Parlato, Ciro; Caraglia, Michele
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts | 1-gen-2012 | Porru, M; Zappavigna, S; Luce, A; Panico, A; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms | 1-gen-2012 | Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele | |
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. | 1-gen-2012 | Marra, M; Salzano, G; Leonetti, C; Porru, M; Franco, Renato; Zappavigna, S; Liguori, G; Botti, G; Chieffi, Paolo; Lamberti, Monica; Vitale, G; Abbruzzese, A; La Rotonda, Mi; De Rosa, G; Caraglia, Michele | |
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. | 1-gen-2012 | Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele | |
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. | 1-gen-2012 | Vitale, G; Zappavigna, S; Marra, M; Dicitore, A; Meschini, S; Condello, M; Arancia, G; Castiglioni, S; Maroni, P; Bendinelli, P; Piccoletti, R; van Koetsveld, Pm; Cavagnini, F; Budillon, A; Abbruzzese, A; Hofland, Lj; Caraglia, Michele | |
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. | 1-gen-2012 | Sanges, C; Scheuermann, C; Zahedi, Rp; Sickmann, A; Lamberti, A; Migliaccio, N; Baljuls, A; Marra, M; Zappavigna, S; Reinders, J; Rapp, U; Abbruzzese, A; Caraglia, Michele; Arcari, P. | |
Autophagic cell death: A new frontier in cancer research | 1-gen-2013 | Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M. | |
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO | 1-gen-2013 | Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele | |
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation | 1-gen-2013 | Perna, A; Sepe, I; Lanza, D; Capasso, R; Zappavigna, S; Capasso, G; Caraglia, M; Ingrosso, D. | |
Interleukin 18: Friend or foe in cancer. | 1-gen-2013 | Palma, G; Barbieri, A; Bimonte, S; Palla, M; Zappavigna, S; Caraglia, Michele; Ascierto, Pa; Ciliberto, G; Arra, C. | |
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. | 1-gen-2013 | Caraglia, Michele; Luongo, Livio; Salzano, G; Zappavigna, S; Marra, M; Guida, Francesca; Lusa, S; Giordano, C; DE NOVELLIS, Vito; Rossi, Francesco; Abbruzzese Saccardi, A; De Rosa, G; Maione, Sabatino | |
Emerging pathways as individualized therapeutic target of multiple myeloma. | 1-gen-2013 | Misso, Gabriella; Zappavigna, S; Castellano, M; De Rosa, G; Di Martino, Mt; Tagliaferri, P; Tassone, P; Caraglia, Michele | |
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? | 1-gen-2013 | Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G. | |
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma | 1-gen-2013 | Leonetti, ; C, ; Porru, ; M, ; Artuso, ; S, ; Zappavigna, S; Luce, ; A, ; Salzano, ; G, ; Lusa, ; S, ; De, Rosa; G, ; Caraglia, ; M, | |
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. | 1-gen-2013 | Troiani, Teresa; Zappavigna, S; Martinelli, Erika; Addeo, Sr; Stiuso, Paola; Ciardiello, Fortunato; Caraglia, Michele | |
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. | 1-gen-2013 | Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele | |
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. | 1-gen-2014 | Franco, Renato; Zappavigna, S; Gigantino, V; Luce, A; Cantile, M; Cerrone, M; Facchini, G; Perdonà, S; Pignata, S; Di Lorenzo, G; Chieffi, Sergio; Vitale, G; DE SIO, Marco; Sgambato, A; Botti, G; Yousif, Am; Novellino, E; Grieco, P; Caraglia, Michele | |
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. | 1-gen-2014 | Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. | 1-gen-2014 | Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele | |
Erlotinib: early clinical development in brain cancer. | 1-gen-2014 | Addeo, R; Zappavigna, S; Parlato, Ciro; Caraglia, Michele |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile